National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
IN THIS ISSUE
Molecular Targets in Cancer Therapy

Drug Discovery at NCI

Animation/VideoAnimation/Video

Audio ClipsAudio Clips

Photos/StillsPhotos/Stills

USEFUL CANCER BACKGROUND
Understanding Cancer Series
Show-and-Tell Tutorials

------

NCI Fact Sheets
Briefs on Cancer Topics

------

NewsCenter
Press Releases

------
SEARCH BENCHMARKS
   
  Between these Dates:      
     
     
Search Benchmarks  
    View All Issues  

MEDIA RESOURCES
Noticias En EspaƱol

Understanding Cancer Series

Visuals Online

B-Roll Footage

Radio Broadcasts

Entertainment Resources

Go To Benchmarks Home Page...
Benchmarks
------
VOLUME 2, ISSUE 3
------
Audio

  1. Louise B. Grochow, M.D., chief of the Investigational Drug Branch, National Cancer Institute speaks at the March 11, 2002, Science Writers Seminar on Molecular Targets in Cancer Therapy:
    Theory to Therapy: Redesigning clinical trials based on advancements in molecular targeting (Part 1)

       ( Audio - Length: 03:49 )                 ( Text Transcript )

  2. Louise B. Grochow, M.D., chief of the Investigational Drug Branch, National Cancer Institute speaks at the March 11, 2002, Science Writers Seminar on Molecular Targets in Cancer Therapy:
    Theory to Therapy: Redesigning clinical trials based on advancements in molecular targeting (Part 2)

       ( Audio - Length: 02:49 )                 ( Text Transcript )

  3. Louise B. Grochow, M.D., chief of the Investigational Drug Branch, National Cancer Institute speaks at the March 11, 2002, Science Writers Seminar on Molecular Targets in Cancer Therapy:
    Issues regarding expertise, cost, and dose-finding in molecular targeting trials (Part 1)

       ( Audio - Length: 01:34 )                 ( Text Transcript )

  4. Louise B. Grochow, M.D., chief of the Investigational Drug Branch, National Cancer Institute speaks at the March 11, 2002, Science Writers Seminar on Molecular Targets in Cancer Therapy:
    Issues regarding expertise, cost, and dose-finding in molecular targeting trials Part 2

       ( Audio - Length: 01:41 )                 ( Text Transcript )

*QuickTime, Winamp, Real Player, or Microsoft Windows Media Player is required to access these files. If you do not have these media players, you can download them free of charge from Apple.com, Winamp.com, Real.com, and Microsoft.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov